Abstract
Summary
Coronavirus vaccines refer to biological products made from coronaviruses for vaccination. It mainly includes inactivated coronavirus vaccine, live attenuated coronavirus vaccine, coronavirus vaccine based on S protein and so on.
According to this study, the global Coronavirus Vaccine market size will reach US$ million by 2029.
This report presents a comprehensive overview, market shares, and growth opportunities of Coronavirus Vaccine market by product type, application, key players and key regions and countries.
Segmentation by product type:
Coronavirus Inactivated Vaccine
Live Attenuated Coronavirus Vaccine
Coronavirus Vaccine Based On S Protein
Segmentation by Application:
Hospital
Clinic
Research Institute
Other
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Іnоvіо Рhаrmасеutісаlѕ
Моdеrnа
Nоvаvах
Рrоtеіn Роtеntіаl
АlрhаVах
Ѕуnаіrgеn РLС
NаnоVіrісіdеѕ
GGеnеСurе
According to this study, the global Coronavirus Vaccine market size will reach US$ million by 2029.
This report presents a comprehensive overview, market shares, and growth opportunities of Coronavirus Vaccine market by product type, application, key players and key regions and countries.
Segmentation by product type:
Coronavirus Inactivated Vaccine
Live Attenuated Coronavirus Vaccine
Coronavirus Vaccine Based On S Protein
Segmentation by Application:
Hospital
Clinic
Research Institute
Other
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Іnоvіо Рhаrmасеutісаlѕ
Моdеrnа
Nоvаvах
Рrоtеіn Роtеntіаl
АlрhаVах
Ѕуnаіrgеn РLС
NаnоVіrісіdеѕ
GGеnеСurе
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Coronavirus Vaccine Market Size 2024-2029
2.1.2 Coronavirus Vaccine Market Size CAGR by Region
2.2 Coronavirus Vaccine Segment by Type
2.2.1 Coronavirus Inactivated Vaccine
2.2.2 Live Attenuated Coronavirus Vaccine
2.2.3 Coronavirus Vaccine Based On S Protein
2.3 Coronavirus Vaccine Market Size by Type
2.3.1 Global Coronavirus Vaccine Market Size Market Share by Type (2024-2029)
2.3.2 Global Coronavirus Vaccine Market Size Growth Rate by Type (2024-2029)
2.4 Coronavirus Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Institute
2.4.4 Other
2.5 Coronavirus Vaccine Market Size by Application
2.5.1 Global Coronavirus Vaccine Market Size Market Share by Application (2024-2029)
2.5.2 Global Coronavirus Vaccine Market Size Growth Rate by Application (2024-2029)
3 Coronavirus Vaccine Key Players
3.1 Date of Key Players Enter into Coronavirus Vaccine
3.2 Key Players Coronavirus Vaccine Product Offered
3.3 Key Players Coronavirus Vaccine Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Coronavirus Vaccine Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Coronavirus Vaccine by Regions
4.1 Coronavirus Vaccine Market Size by Regions (2024-2029)
4.2 United States Coronavirus Vaccine Market Size Growth (2024-2029)
4.3 China Coronavirus Vaccine Market Size Growth (2024-2029)
4.4 Europe Coronavirus Vaccine Market Size Growth (2024-2029)
4.5 Rest of World Coronavirus Vaccine Market Size Growth (2024-2029)
5 United States
5.1 United States Coronavirus Vaccine Market Size by Type (2024-2029)
5.2 United States Coronavirus Vaccine Market Size by Application (2024-2029)
6 Europe
6.1 Europe Coronavirus Vaccine Market Size by Type (2024-2029)
6.2 Europe Coronavirus Vaccine Market Size by Application (2024-2029)
7 China
7.1 China Coronavirus Vaccine Market Size by Type (2024-2029)
7.2 China Coronavirus Vaccine Market Size by Application (2024-2029)
8 Rest of World
8.1 Rest of World Coronavirus Vaccine Market Size by Type (2024-2029)
8.2 Rest of World Coronavirus Vaccine Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Coronavirus Vaccine
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 Іnоvіо Рhаrmасеutісаlѕ
11.1.1 Іnоvіо Рhаrmасеutісаlѕ Company Details
11.1.2 Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Product Offered
11.1.3 Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Market Size (2023 VS 2029)
11.1.4 Іnоvіо Рhаrmасеutісаlѕ Main Business Overview
11.1.5 Іnоvіо Рhаrmасеutісаlѕ News
11.2 Моdеrnа
11.2.1 Моdеrnа Company Details
11.2.2 Моdеrnа Coronavirus Vaccine Product Offered
11.2.3 Моdеrnа Coronavirus Vaccine Market Size (2023 VS 2029)
11.2.4 Моdеrnа Main Business Overview
11.2.5 Моdеrnа News
11.3 Nоvаvах
11.3.1 Nоvаvах Company Details
11.3.2 Nоvаvах Coronavirus Vaccine Product Offered
11.3.3 Nоvаvах Coronavirus Vaccine Market Size (2023 VS 2029)
11.3.4 Nоvаvах Main Business Overview
11.3.5 Nоvаvах News
11.4 Рrоtеіn Роtеntіаl
11.4.1 Рrоtеіn Роtеntіаl Company Details
11.4.2 Рrоtеіn Роtеntіаl Coronavirus Vaccine Product Offered
11.4.3 Рrоtеіn Роtеntіаl Coronavirus Vaccine Market Size (2023 VS 2029)
11.4.4 Рrоtеіn Роtеntіаl Main Business Overview
11.4.5 Рrоtеіn Роtеntіаl News
11.5 АlрhаVах
11.5.1 АlрhаVах Company Details
11.5.2 АlрhаVах Coronavirus Vaccine Product Offered
11.5.3 АlрhаVах Coronavirus Vaccine Market Size (2023 VS 2029)
11.5.4 АlрhаVах Main Business Overview
11.5.5 АlрhаVах News
11.6 Ѕуnаіrgеn РLС
11.6.1 Ѕуnаіrgеn РLС Company Details
11.6.2 Ѕуnаіrgеn РLС Coronavirus Vaccine Product Offered
11.6.3 Ѕуnаіrgеn РLС Coronavirus Vaccine Market Size (2023 VS 2029)
11.6.4 Ѕуnаіrgеn РLС Main Business Overview
11.6.5 Ѕуnаіrgеn РLС News
11.7 NаnоVіrісіdеѕ
11.7.1 NаnоVіrісіdеѕ Company Details
11.7.2 NаnоVіrісіdеѕ Coronavirus Vaccine Product Offered
11.7.3 NаnоVіrісіdеѕ Coronavirus Vaccine Market Size (2023 VS 2029)
11.7.4 NаnоVіrісіdеѕ Main Business Overview
11.7.5 NаnоVіrісіdеѕ News
11.8 GGеnеСurе
11.8.1 GGеnеСurе Company Details
11.8.2 GGеnеСurе Coronavirus Vaccine Product Offered
11.8.3 GGеnеСurе Coronavirus Vaccine Market Size (2023 VS 2029)
11.8.4 GGеnеСurе Main Business Overview
11.8.5 GGеnеСurе News
12 Research Findings and Conclusion